Literature DB >> 25574843

Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau.

Ismael Santa-Maria, Maria E Alaniz, Neil Renwick, Carolina Cela, Tudor A Fulga, David Van Vactor, Thomas Tuschl, Lorraine N Clark, Michael L Shelanski, Brian D McCabe, John F Crary.   

Abstract

Tau is a highly abundant and multifunctional brain protein that accumulates in neurofibrillary tangles (NFTs), most commonly in Alzheimer's disease (AD) and primary age-related tauopathy. Recently, microRNAs (miRNAs) have been linked to neurodegeneration; however, it is not clear whether miRNA dysregulation contributes to tau neurotoxicity. Here, we determined that the highly conserved brain miRNA miR-219 is downregulated in brain tissue taken at autopsy from patients with AD and from those with severe primary age-related tauopathy. In a Drosophila model that produces human tau, reduction of miR-219 exacerbated tau toxicity, while overexpression of miR-219 partially abrogated toxic effects. Moreover, we observed a bidirectional modulation of tau levels in the Drosophila model that was dependent on miR-219 expression or neutralization, demonstrating that miR-219 regulates tau in vivo. In mammalian cellular models, we found that miR-219 binds directly to the 3'-UTR of the tau mRNA and represses tau synthesis at the post-transcriptional level. Together, our data indicate that silencing of tau by miR-219 is an ancient regulatory mechanism that may become perturbed during neurofibrillary degeneration and suggest that this regulatory pathway may be useful for developing therapeutics for tauopathies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25574843      PMCID: PMC4319412          DOI: 10.1172/JCI78421

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries.

Authors:  Markus Hafner; Neil Renwick; Miguel Brown; Aleksandra Mihailović; Daniel Holoch; Carolina Lin; John T G Pena; Jeffrey D Nusbaum; Pavel Morozov; Janos Ludwig; Tolulope Ojo; Shujun Luo; Gary Schroth; Thomas Tuschl
Journal:  RNA       Date:  2011-07-20       Impact factor: 4.942

Review 2.  Exploiting Drosophila genetics to understand microRNA function and regulation.

Authors:  Qi Dai; Peter Smibert; Eric C Lai
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

Review 3.  Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: the need of larger datasets.

Authors:  Pierre Lau; Carlo Sala Frigerio; Bart De Strooper
Journal:  Ageing Res Rev       Date:  2014-03-04       Impact factor: 10.895

Review 4.  MicroRNAs in neuronal function and dysfunction.

Authors:  Heh-In Im; Paul J Kenny
Journal:  Trends Neurosci       Date:  2012-03-19       Impact factor: 13.837

5.  Identification and characterization of the Drosophila tau homolog.

Authors:  G Heidary; M E Fortini
Journal:  Mech Dev       Date:  2001-10       Impact factor: 1.882

6.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

Review 7.  MicroRNAs and neurodegeneration: role and impact.

Authors:  Masashi Abe; Nancy M Bonini
Journal:  Trends Cell Biol       Date:  2012-09-28       Impact factor: 20.808

8.  Primary age-related tauopathy (PART): a common pathology associated with human aging.

Authors:  John F Crary; John Q Trojanowski; Julie A Schneider; Jose F Abisambra; Erin L Abner; Irina Alafuzoff; Steven E Arnold; Johannes Attems; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Marla Gearing; Lea T Grinberg; Patrick R Hof; Bradley T Hyman; Kurt Jellinger; Gregory A Jicha; Gabor G Kovacs; David S Knopman; Julia Kofler; Walter A Kukull; Ian R Mackenzie; Eliezer Masliah; Ann McKee; Thomas J Montine; Melissa E Murray; Janna H Neltner; Ismael Santa-Maria; William W Seeley; Alberto Serrano-Pozo; Michael L Shelanski; Thor Stein; Masaki Takao; Dietmar R Thal; Jonathan B Toledo; Juan C Troncoso; Jean Paul Vonsattel; Charles L White; Thomas Wisniewski; Randall L Woltjer; Masahito Yamada; Peter T Nelson
Journal:  Acta Neuropathol       Date:  2014-10-28       Impact factor: 17.088

9.  Alteration of the microRNA network during the progression of Alzheimer's disease.

Authors:  Pierre Lau; Koen Bossers; Rekin's Janky; Evgenia Salta; Carlo Sala Frigerio; Shahar Barbash; Roy Rothman; Annerieke S R Sierksma; Amantha Thathiah; David Greenberg; Aikaterini S Papadopoulou; Tilmann Achsel; Torik Ayoubi; Hermona Soreq; Joost Verhaagen; Dick F Swaab; Stein Aerts; Bart De Strooper
Journal:  EMBO Mol Med       Date:  2013-09-09       Impact factor: 12.137

10.  Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation.

Authors:  Lorenzo F Sempere; Sarah Freemantle; Ian Pitha-Rowe; Eric Moss; Ethan Dmitrovsky; Victor Ambros
Journal:  Genome Biol       Date:  2004-02-16       Impact factor: 13.583

View more
  69 in total

1.  Profiling of Argonaute-2-loaded microRNAs in a mouse model of frontotemporal dementia with parkinsonism-17.

Authors:  Aidan Kenny; Félix Hernández; Jesús Avila; José J Lucas; David C Henshall; Jochen Hm Prehn; Eva M Jiménez-Mateos; Tobias Engel
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-12-25

2.  MicroRNA-153 improves the neurogenesis of neural stem cells and enhances the cognitive ability of aged mice through the notch signaling pathway.

Authors:  Jing Qiao; Jinping Zhao; Shujuan Chang; Qiaoyi Sun; Nana Liu; Jianfeng Dong; Yafang Chen; Dandan Yang; Dan Ye; Xiaoqin Liu; Yangyang Yu; Wen Chen; Songcheng Zhu; Guiying Wang; Wenwen Jia; Jiajie Xi; Jiuhong Kang
Journal:  Cell Death Differ       Date:  2019-07-11       Impact factor: 15.828

Review 3.  Emerging Diagnostic and Therapeutic Strategies for Tauopathies.

Authors:  David Coughlin; David J Irwin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

Review 4.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

5.  Tau in Alzheimer's Disease: Pathological Alterations and an Attractive Therapeutic Target.

Authors:  Jian-Lan Gu; Fei Liu
Journal:  Curr Med Sci       Date:  2021-01-11

6.  Expression of microRNAs targeting heat shock protein B8 during in vitro expansion of dental pulp stem cells in regulating osteogenic differentiation.

Authors:  Shaomian Yao; Chunhong Li; Angelle M Budenski; Patricia Li; Alexandra Ramos; Steven Guo
Journal:  Arch Oral Biol       Date:  2019-07-22       Impact factor: 2.633

Review 7.  A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Sahil Tonk; Subodh Kumar; Murali Vijayan; Ramesh Kandimalla; Chandra Sekhar Kuruva; Arubala P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

Review 8.  Noncoding RNAs in neurodegeneration.

Authors:  Evgenia Salta; Bart De Strooper
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

Review 9.  The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy.

Authors:  Cheng-Cheng Zhang; Ang Xing; Meng-Shan Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-09-12       Impact factor: 5.590

10.  miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.

Authors:  Pascal Y Smith; Julia Hernandez-Rapp; Francis Jolivette; Cynthia Lecours; Kanchan Bisht; Claudia Goupil; Veronique Dorval; Sepideh Parsi; Françoise Morin; Emmanuel Planel; David A Bennett; Francisco-Jose Fernandez-Gomez; Nicolas Sergeant; Luc Buée; Marie-Ève Tremblay; Frédéric Calon; Sébastien S Hébert
Journal:  Hum Mol Genet       Date:  2015-09-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.